Kyverna Therapeutics Closes $85 Million Series B Financing Led By Northpond Ventures
Amount Raised
$85 Million
Round Type
Series B
EmeryvilleBiotechnologyHealth CareScience And EngineeringDescription
Kyverna Therapeutics ("Kyverna"), a cell therapy company engineering a new class of therapies for serious autoimmune diseases, today announced it has closed an oversubscribed $85 million Series B financing round led by Northpond Ventures. Additional investors included the company's founding investors Westlake Village BioPartners ("Westlake"), Vida Ventures, and Gilead Sciences ("Gilead"), with new investors RTW Investments, LP ("RTW"), CAM Capital, Insight Partners, HealthCor, LYFE Capital, Intellia Therapeutics, Argentum Peak, Hudson Bay Capital, and jVen Capital.
Quick answer
Kyverna Therapeutics raised $85 Million in a Series B round, dated January 26, 2022. Kyverna Therapeutics is based in Emeryville, California, United States.
- How much did Kyverna Therapeutics raise?
- Kyverna Therapeutics raised $85 Million in a Series B round on January 26, 2022.
- What does Kyverna Therapeutics do?
- Kyverna is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases.
- Where is Kyverna Therapeutics based and how big is it?
- Kyverna Therapeutics is based in Emeryville, California, United States. Fundz records about 120 employees.
- Who are the decision-makers at Kyverna Therapeutics?
- Fundz holds 1 contact at Kyverna Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Science And Engineering and Biotechnology around the same time
Companies in the same sectors as Kyverna Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Psilera raised an undisclosed amount (Funding Round) on March 8, 2022.
- Sherlock Biosciences raised $80M (Series B) on March 8, 2022.
- Walking Fish Therapeutics raised $13M on March 3, 2022.
- SeLux Diagnostics, Inc. raised $50M (Series C) on February 28, 2022.
- Appili Therapeutics Inc. raised $10M (Funding Round) on February 28, 2022.
- Synthego Corp raised $200M (Funding Round) on February 17, 2022.
Who to call at Kyverna Therapeutics, and when
A new round usually means Kyverna Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Kyverna Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Kyverna Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Kyverna Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Kyverna Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansKyverna Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.